pocketful logo light
pocketful logo light
Artemis Medicare Services Ltd logo

Artemis Medicare Services Ltd

NSE: ARTEMISMED BSE: 542919

₹274.95

(1.55%)

Thu, 30 Jul 2026, 11:22 am

Artemis Medicare Services EV/EBITDA Ratio

Particulars201320142015201620172018201920202021202220232024
Price to earnings ratio000024.6919.649.2345.3220.0624.4448.1251.77
Price to book ratio00002.381.370.580.921.692.265.154.51
Price to sales ratio00001.290.750.330.721.151.282.694.57
Price to cash flow ratio00008.4712.243.9716.1112.378.3727.8231.81
Enterprise value0000726Cr504Cr281Cr411Cr813Cr1183Cr2630Cr4178Cr
Enterprise value to EBITDA ratio000011.998.585.0411.4311.9712.3519.5626.93
Debt to equity ratio0000.380.330.390.360.460.560.710.710.35
Return on equity %0-11.1384.6421.979.937.236.522.059.3610.1211.5412.85

Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio

The Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Artemis Medicare Services Ltd's valuation, profitability, and overall financial performance. Tracking the Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Artemis Medicare Services Ltd (NSE: ARTEMISMED, BSE: 542919) is currently trading at ₹274.95, with a market capitalization of ₹4269.52Cr. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio Current Value

The current Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio stands at 26.93.

The latest Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

  • 2024: 26.93
  • 2023: 19.56
  • 2022: 12.35
  • 2021: 11.97
  • 2020: 11.43

The recent rise in Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Artemis Medicare Services Ltd.

Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Artemis Medicare Services Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account

Enter your phone number